PR Newswire Clinical TrialsOriginal article
Nanochon Receives Regulatory Approval from Panamá's Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™
Trial StartapprovedChondrograft™Positive
AI Analysis
Summary
Nanochon received regulatory approval from Panamá's Ministry of Health to begin a first-in-human clinical study of Chondrograft™, a novel implant for treating knee articular cartilage defects.
Clinical Trial Data
Phase
Phase_1
Outcome Details
Regulatory approval received from Panamá's Ministry of Health to initiate first-in-human clinical study
Importance:5/10
Sentiment:
0.70
medical deviceregulatory approvalclinical trialfirst-in-humanorthopedicscartilage repair
Read the original article
Published by PR Newswire Clinical Trials on August 14, 2026 3:21 PM